Clinical Trial Update: A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety and efficacy of a combination of Carboplatin, Paclitaxel, Bevacizumab, and CA4P in non-small cell lung cancer, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CA4P (combretastatin A-4 phosphate)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Mateon Therapeutics | Conditions: Tumors | Phase 2 | Status: COMPLETED | Results posted: 2015-02-09